Hollister L E, Davis K L, Berger P A
Psychopharmacol Commun. 1975;1(5):493-500.
Butaclamol hydrochloride, a new type of antipsychotic drug, was evaluated by an uncontrolled study of 13 newly admitted schizophrenic patients. The drug had antipsychotic effects as well as a strong propensity for evoking extrapyramidal side effects. With the maximal daily doses of 30 mg used in this study, therapeutic results obtained were probably somewhat less than optimal.
盐酸布他拉莫，一种新型抗精神病药物，通过对13名新入院精神分裂症患者的非对照研究进行了评估。该药物具有抗精神病作用，同时也有诱发锥体外系副作用的强烈倾向。在本研究中使用的最大日剂量为30毫克，所获得的治疗效果可能略逊于最佳效果。
